Intranasal Delivery of Recombinant S100A8 Protein Delays Lung Cancer Growth by Remodeling the Lung Immune Microenvironment.

Front Immunol · 2022 · PMC9152328 · PMID 35655772

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Similarly, S100A8 significantly reduced percentages of total and M-MDSC in spleens from mice with LLC cancers (Total MDSC: 1.10 ± 0.15% to 0.62 ± 0.10%, p < 0.05; M-MDSC: 0.18 ± 0.04% to 0.07 ± 0.01%, p < 0.05); PMN-MDSC showed a trend of decrease ( Figures 5J–L ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.